Inspire Medical Systems
INSP | NYSE
$59.12
-$1.98 (-3.24%)
At close: Nov 16, 2026, 4:00 PM ET
$59.12
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:00 PM ET
Inspire Medical Systems Company Profile
Company profile explainedCompany Profile
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Key Executives
| Name | Position |
|---|---|
| Timothy Herbert | Founder, Chairman, Chief Executive Officer & President |
| Melissa J. Mann | Chief People Officer |
| Andreas Henke | Executive VP International & MD |
| Bryan K. Phillips | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
| Carlton W. Weatherby | Chief Strategy and Growth Officer |
| Ivan Lubogo | SVP of Strategic Sales |
| Jason Kelly | Chief Operations & Innovation Officer |
| Joseph E. Sander | Senior Vice President of U.S. Sales |
| Matthew J. Osberg | Executive VP & CFO |
| Megan Rowekamp | Director of Financial Reporting |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 16, 2026 | 4 | Filing |
| Oct 16, 2026 | 4 | Filing |
| Oct 16, 2026 | 4 | Filing |
| Oct 16, 2026 | 4 | Filing |
| Sep 02, 2026 | 4 | Filing |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 11, 2026 | 4 | Filing |
| Aug 04, 2026 | 4 | Filing |
Inspire Medical Systems
| Country | United States |
| IPO Date | May 3, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 1,333 |
| CEO | Timothy Herbert |
Contact Details
5500 Wayzata Boulevard Golden Valley,
Minnesota 55416 United States
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| SIC Code | 3841 |
Recent News
- 5 days ago / zacks.comHere's Why You Should Retain INSP Stock in Your Portfolio for Now
- 6 days ago / zacks.comINSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?
- 13 days ago / seekingalpha.comInspire Medical Systems: The Moat Just Passed Its Worst-Case Stress Test
- 13 days ago / globenewswire.comInspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
- 14 days ago / benzinga.comThese Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results
- 14 days ago / seekingalpha.comInspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call Transcript
- 14 days ago / marketbeat.comInspire Medical Systems Q3 Earnings Call Highlights
- 14 days ago / zacks.comInspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
- 14 days ago / zacks.comHere's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
- 14 days ago / globenewswire.comInspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
Add to Watchlist
Select watchlists to add or remove INSP